Publications Anna Dimberg

Publications in DiVA

Publications in PubMed

Selected publications:

  1. Georganaki M, Ramachandran M, Tuit S, Núñez NG, Karampatzakis A, Fotaki G, van Hooren L, Huang H, Lugano R, Ulas T, Kaunisto A, Holland EC, Ellmark P, Mangsbo SM, Schultze J, Essand M, Tugues S, Dimberg A. Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism than reduces the response to CD40-stimulating immunotherapy. Oncoimmunology. 2020, 9(1):1730538. doi: 10.1080/2162402X.2020.1730538. eCollection 2020. PMID: 32231867.
     
  2. Zhang L, He L, Lugano R, Roodakker K, Bergquist M, Smits A, Dimberg A. IDH-mutation status is associated with distinct vascular gene expression signatures in lower grade gliomas. Neuro Oncol. 2018, May 29. doi:10.1093/neuonc/noy088. PMID: 29846705.
     
  3. Lugano R, Vemuri K, Yu D, Bergqvist M, Smits A, Essand M, Johansson S, Dejana E, Dimberg A. CD93 promotes integrin-β1 activation and fibronectin fibrillogenesis during tumor angiogenesis. J Clin Invest. 2018, May 15. pii: 97459. doi: 10.1172/JCI97459. [PMID:29763414
     
  4. Zhang L, Laaniste L, Jiang Y, Alafuzoff  I, Uhrbom L, Dimberg A. Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells. Oncotarget. 2016, 7(49):80382-80390.
     
  5. van Hooren L, Georganaki M, Huang H, Mangsbo SM, Dimberg A. Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment. Oncotarget. 2016, Jul 1. doi: 10.18632/oncotarget.10364.  
     
  6. Zhang L, Kundu S, Feenstra T, Li X, Jin C, Laaniste L, Elsir T, Ohlin EK, Yu D, Olofsson T, Olsson AK, Pontén F, Magnusson PU, Forsberg Nilsson K, Essand M, Smits A, Dieterich LC, Dimberg A. Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas. Science Signaling, 2015, 8(406):ra125. PMID:26645582.
     
  7. Langenkamp E,  Zhang L, Lugano R, Huang H, Abu Elhassan TE, Georganaki M, Bazzar W, Lööf J, Trendelenburg G, Essand M, Pontén F, Smits A, Dimberg A. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival. Cancer Research. 2015, 75(21):4504-16. PMID:26363010.
     
  8. Huang H, Langenkamp E, Georganaki M, Loskog A, Fredlund Fuchs P, Dieterich LC, Kreuger J, Dimberg A. VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation. FASEB J. 2015, 29(1):227-38. PMID:25361735.
     
  9. Dieterich L, Schiller P, Huang H, Wawrousek E, Moons L, Dimberg A. αB-crystallin regulates expansion of CD11b+Gr1+ immature myeloid cells during tumor progression. FASEB J. 2013, 27(1):151-62. PMID:23575676.
     
  10. Dieterich LC, Mellberg S, Zhang L, Langenkamp E, Salomäki H, Olofsson T, Larsson E, Molema G, Pontén F, Georgii-Hemming P, Alafuzoff I, Dimberg A. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFb2 in vascular abnormalization. J Pathol. 2012, 228(3):378-90. PMID:22786655.

Last modified: 2021-01-29